6-(4-Chlorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a]azepine, 98%, 100mg

5-Amino-8-chloroquinoline, 95.0%, 1g

N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-((4-methoxyphenyl)diphenylmethyl)-L-lysine, 97%, 5g

3-Bromophthalic anhydride, 97.0%, 1g

2-Bromo-1,1,1-trifluoro-pentane, 5g

3-(4-Chloro-phenyl)-3-oxo-propionic acid methylester, 95.0%, 25g

1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide Hydrochloride [Coupling Agent for Peptides Synthesis]>98.0%(T)100g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)-2-methylhexanoic acid, 97%, 100mg

5-Methylpyrazin-2-amine, 99.0%, 5g

Methyl 2,6-difluoro-3-hydroxybenzoate, 95.0%, 250mg

1-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDAZOLE, 95.0%, 100mg

(S)-(4-Methylmorpholin-2-yl)methanamine, 97%, 250mg

2-Methyl-1(4-trifluoromethoxyphenyl)propan-1-one, 95.0%, 1g